A el-Jammal, D M Templeton
Index: J. Chromatogr. B, Biomed. Appl. 658(1) , 121-7, (1994)
Full Text: HTML
The pursuit of orally available Fe(III) chelating agents has resulted in several clinical trials of 1,2-dimethyl-3-hydroxypyrid-4-one (CP20). Chromatography of this and related Fe chelators on silica-based columns has proven difficult due to unwanted interactions with the stationary phase, including with contaminating Fe bound to silanol groups. By addition of Fe3+ (50 microM ferric ammonium citrate) to an acidified aqueous mobile phase, we have successfully separated a series of hydroxypyridones-including CP20-and the related pyrones maltol and ethylmaltol by HPLC on microBondapak C18. Complexation occurs with these agents even at low pH, and they elute in an order consistent with the partition coefficients of their Fe(III) complexes. By the reverse strategy of adding ethylmaltol to the mobile phase, chelatable Fe was chromatographed and the peak response at 500 nm was linear down to a detection limit below 0.5 microM. This method was applied to pooled serum and to serum spiked with Fe after filtration at 10 kDa cut-off. The direct determination of non-transferrin-bound Fe at micromolar concentrations in serum is possible with this approach.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Ethyl maltol
CAS:4940-11-8 |
C7H8O3 |
Perceptual blending in odor mixtures depends on the nature o...
2012-02-01 [Chem. Senses 37(2) , 159-66, (2012)] |
Vanadium treatment of type 2 diabetes: A view to the future
2009-01-01 [J. Inorg. Biochem. 103(4) , 554-8, (2009)] |
Facilitated uptake of zinc into human erythrocytes. Relevanc...
1990-03-15 [Biochem. Pharmacol. 39(6) , 1005-12, (1990)] |
Characteristics of iron(III) uptake by isolated fragments of...
1988-05-15 [Biochem. Pharmacol. 37(10) , 2051-7, (1988)] |
Lead transport and binding by human erythrocytes in vitro.
1993-05-01 [Pflugers Arch. 423(3-4) , 307-13, (1993)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved